Ebola virus entry inhibitors (Arisan Therapeutics)

N/A

Report date: 2025/03/18 18:15:02
NME

Base Information

Drug NameEbola virus entry inhibitors (Arisan Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArisan Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArisan Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A